lifestyle.buyersdesire.org

Author: Daniel J. Edelman Inc. dba Edelman on behalf of itself and its Affiliates

Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)

March 12, 2026
Magnum Brings Dessert to the Desert as Coachella’s First-Ever Frozen Dessert Sponsor

March 11, 2026
TACO BELL’S LIVE MÁS LIVE IS BACK AS A MUST-WATCH SPECTACLE, WHERE 2026 MENU REVEALS COLLIDE WITH HOLLYWOOD STAR POWER – STREAMING FOR THE FIRST TIME EVER ON PEACOCK

March 11, 2026
Butterball Cook from Frozen Premium Whole Turkey Wins Distinguished Product Award

March 11, 2026
FDA Approves VUEWAY® (gadopiclenol) Solution for Injection, Intravenous Use, for Use in Neonates and Infants

March 11, 2026
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line recurrent or metastatic head and neck cancer

March 11, 2026
Chicken Bacon Ranch Street Chalupas Hit Taco Bell® Menus Giving a Familiar Flavor a Street Taco Twist

March 11, 2026
Blue Earth Diagnostics to Highlight New POSLUMA® (Flotufolastat F 18) Study Results in Prostate Cancer at the 2026 ASCO Genitourinary Symposium (ASCO GU)

March 11, 2026
The Hefty® Brand Expands Partnership with John Cena in New ‘Strong Choice’ Campaign Showcasing Full Portfolio – From Trash Bags to Food Storage Bags and Cups

March 11, 2026
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer

March 11, 2026